SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Saipem S.p.A. (SAPMD) trades at a trailing P/E of 1.7. Trailing earnings yield is 59.88%. PEG 0.03 (Peter Lynch undervalued ≤1.0).
Criteria proven by this page:
- VALUE (100/100, Pass) — P/E is below market average (1.7); PEG ≤ 1.0 — Peter Lynch undervalued (0.03); earnings yield beats bond yields (59.88%).
- PEG Ratio 0.03 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
- Trailing Earnings Yield 59.88% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income.
Overall SharesGrow Score: 65/100 with 2/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
100/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — SAPMD
Valuation Multiples
P/E (TTM)1.7
Forward P/EN/A
PEG Ratio0.03
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.04
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.15
Book Value / Share$0.00
Revenue / Share$6.51
FCF / Share$0.00
Yields & Fair Value
Earnings Yield59.88%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$-948.51 |
$12.51B |
$-875.37M |
-7% |
| 2016 |
$-125.29 |
$10.53B |
$-2.2B |
-20.9% |
| 2017 |
$-18.73 |
$10.81B |
$-393.52M |
-3.6% |
| 2018 |
$-25.85 |
$9.78B |
$-540.73M |
-5.5% |
| 2019 |
$0.63 |
$10.21B |
$13.46M |
0.1% |
| 2020 |
$-66.64 |
$9.04B |
$-1.39B |
-15.4% |
| 2021 |
$-2.91 |
$7.43B |
$-2.74B |
-36.9% |
| 2022 |
$-0.36 |
$10.69B |
$-337.3M |
-3.2% |
| 2023 |
$0.09 |
$11.88B |
$179M |
1.5% |
| 2024 |
$0.15 |
$14.55B |
$306M |
2.1% |
